Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Briacell Therapeutics Corp (BCT.TO)
Briacell Therapeutics Corp (BCT.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 133,605
  • Shares Outstanding, K 15,981
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,550 K
  • 60-Month Beta 1.53
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BCT.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.53
  • Most Recent Earnings -0.77 on 03/16/23
  • Next Earnings Date 06/12/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.78 +7.46%
on 05/18/23
9.80 -14.69%
on 05/09/23
-1.36 (-13.99%)
since 05/08/23
3-Month
7.78 +7.46%
on 05/18/23
10.45 -20.00%
on 04/03/23
-1.30 (-13.46%)
since 03/08/23
52-Week
5.77 +44.89%
on 12/30/22
10.91 -23.37%
on 09/07/22
+0.78 (+10.29%)
since 06/08/22

Most Recent Stories

More News
Stocks in play: BriaCell Therapeutics Corp.

Announced that it has entered into an arrangement agreement dated May 24, 2023 with BriaPro Therapeutics ...

BCT.TO : 8.36 (+1.58%)
There are Positive Developments in the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is desperately needed in the fight against metastatic breast cancer. As it stands right now, metastatic breast cancer has no cure and has proven resistant to many cancer...

LLY : 443.61 (-0.46%)
PBYI : 3.51 (-1.68%)
GILD : 77.40 (-1.28%)
IMGN : 16.43 (+4.32%)
BCTX : 6.29 (+2.28%)
BCT.TO : 8.36 (+1.58%)
Stocks in play: BriaCell Therapeutics Corp

Announces the Company has completed the previously-announced strategic investment by Prevail Partners, ...

BCT.TO : 8.36 (+1.58%)
Stocks in play: BriaCell Therapeutics Corp.

Announced that the Company has signed a Master Service and Technology Agreement agreement with Prevail ...

BCT.TO : 8.36 (+1.58%)
Five Impressive Metastatic Cancer Treatment Stocks to Own Today

A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone...

LLY : 443.61 (-0.46%)
PBYI : 3.51 (-1.68%)
GILD : 77.40 (-1.28%)
IMGN : 16.43 (+4.32%)
BCTX : 6.29 (+2.28%)
BCT.TO : 8.36 (+1.58%)
Stocks in play: BriaCell Therapeutics Corp.

Is presenting positive clinical data from its lead product candidate, Bria-IMT™, summarized in four ...

BCT.TO : 8.36 (+1.58%)
Positive Developments for Breast Cancer Care Attracting Big Investor Attention

A significant medical breakthrough is sorely needed in the fight against breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of invasive...

BCTX : 6.29 (+2.28%)
PFE : 39.11 (+0.05%)
GILD : 77.40 (-1.28%)
PBYI : 3.51 (-1.68%)
MRK : 109.16 (-1.05%)
BCT.TO : 8.36 (+1.58%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2023 – USA News Group  –  Treatments for various forms of breast cancer continue to evolve, with several new...

BCTX : 6.29 (+2.28%)
ONCY : 1.5800 (-0.63%)
ONC.TO : 2.10 (unch)
CTMX : 1.7200 (-1.15%)
BCT.TO : 8.36 (+1.58%)
RLAY : 11.01 (-1.34%)
HOLX : 78.08 (-0.13%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

/PRNewswire/ -- USA News Group - Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in...

BCTXW : 2.69 (+1.88%)
ONC.TO : 2.10 (unch)
BCT.TO : 8.36 (+1.58%)
ONCY : 1.5800 (-0.63%)
CTMX : 1.7200 (-1.15%)
BCTX : 6.29 (+2.28%)
RLAY : 11.01 (-1.34%)
HOLX : 78.08 (-0.13%)
FDA’s Wave of Fast Track Designations Pushing Momentum in Healthcare Sector in 2023

USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food and Drug Administration (FDA) granted several approvals and new Fast Track designations towards...

ONCY : 1.5800 (-0.63%)
ONC.TO : 2.10 (unch)
RHHBY : 39.4000 (-0.10%)
FULC : 3.18 (+0.95%)
RNA : 11.80 (-0.76%)
BCTX : 6.29 (+2.28%)
BCT.TO : 8.36 (+1.58%)
GILD : 77.40 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 8.77
2nd Resistance Point 8.61
1st Resistance Point 8.49
Last Price 8.36
1st Support Level 8.21
2nd Support Level 8.05
3rd Support Level 7.93

See More

52-Week High 10.91
Fibonacci 61.8% 8.95
Last Price 8.36
Fibonacci 50% 8.34
Fibonacci 38.2% 7.73
52-Week Low 5.77

See More

Business Summary

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in advanced metastatic breast cancer. Additionally, it is developing Bria-OTS,...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar